Home » China Private Equity »

|| Chinese PE firm TMCP invested $2.4 million in US firm RNAimmune

ping anChinese private equity firm Terra Magnum Capital Partners has invested $2.35 million in US-based RNAimmune

Founded in 2016, Terra Magnum Capital Partners (TMCP) has over $800 million assets under management and specializes in both direct investments and fund investments. It has offices in Beijing, Shanghai and United States. Sha Wang, Ben Wang, Ray Yang, Frank Qin, Ming Liu and Justin Chang are among their partners and directors. (RNAimmune is a biopharmaceutical company in Gaithersburg with more than 20 years of experience in cancer therapies, antibody therapies and treatment of rare diseases)

Terra Magnum Capital Partners is listed in the Chinese Investors Directory with the code SJ78

Previous Post: Chinese investors of NLVC acquired stake in California startup for $7 million
Next Post: Chinese angel investor Alvin Tse invests in US firm People Mesh

More from China Private Equity ...

  Chinese private equity firm and consortium invested $75 million in US firm Nobell Foods

  Chinese firm CreditEase and consortium invested $250 million in US firm Pipe

  Chinese PE firm TMCP invested $2.4 million in US firm RNAimmune

  Chinese investors of Ping An acquired stake in Israel MeMed for $70 million

  Chinese private equity firm to invest $270 million in blockchain firm tZero

  China Gaw Capital acquired 50% stake in Spanish hotel chain valued at $145 million

  Chinese firm Beijing Bytedance acquired Musical.ly for $800 million

  Chinese investors of AGIC Capital acquired South Carolina Ritedose for $600 million

  Chinese firm acquired US car assembly plant AM General for $110 million

  Chinese HNA Group acquired stake in Swiss firm Dufry

| About Us

SinaBeat.com provides insight, analysis and research on private investors from China since 2012.

We cover Private Equity, Venture Capital, Real Estate and Institutional Investors from China, Hong Kong and Macau.

Our Chinese Investors Directory can be used as a reliable source on information about investors from China.

|Subscribe to mailing list

Careers  |  Sponsorship |  Sitemap |  Terms  |  Privacy Policy

Copyright 2007 - 2023     SinaBeat.com

Follow us: RSS  |   SinaBeat on Twitter  |   SinaBeat on Facebook  |   SinaBeat on LinkedIn

Powered by Insightice